METHOD FOR PREDICTING ENDOGENOUS UVEITIS DEVELOPMENT COURSE IN CHILDREN
FIELD: medicine. SUBSTANCE: method involves determining antioxidation activity in lacrimal fluid and blood serum. Lacrimal fluid antioxidation activity being equal to or less than 102 mcM and ratio being equal to or less than 0.3, exacerbation or lingering uveitis process is to be predicted. Lacrima...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. SUBSTANCE: method involves determining antioxidation activity in lacrimal fluid and blood serum. Lacrimal fluid antioxidation activity being equal to or less than 102 mcM and ratio being equal to or less than 0.3, exacerbation or lingering uveitis process is to be predicted. Lacrimal fluid antioxidation activity being equal to or greater than 175 mcM and the ratio being equal to or greater than 0.7, favorable development course or remission period is to be predicted. EFFECT: reliable prognosis. _ |
---|